28
total announcements
ZENSARTECH.NS · 15 min delayed
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about ICRA Limited re-affirming the credit rating for Long Term/Short Term-Fund Based/Non-Fund Based as [ICRA]AA+ (Stable)/[ICRA]A1+.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about the allotment of 25,691 fully paid equity shares of Rs. 2/- each to employees against the exercise of ESOPs, increasing the issued and subscribed share capital to Rs. 455,161,426.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about the merger of M3BI LLC with Zensar Technologies Inc. All requisite filings for the merger were completed with local authorities on August 13, 2026, and the merger will become effective from September 1, 2026.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about the schedule of analyst/institutional investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about the schedule of analyst/institutional investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Zensar Technologies Limited
Zensar Technologies Limited has been assigned an ESG Score of 74 by Crisil for the fiscal year 2026, reflecting the company's performance on ESG parameters.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about a special window opened for lodgement of transfer and dematerialization (demat) requests for physical securities sold/purchased prior to April 1, 2019.
Zensar Technologies Limited
Zensar Technologies Limited has made available the transcript of its earnings call held on July 30, 2026, discussing its financial results for the quarter ended June 30, 2026.
Zensar Technologies Limited
Zensar Technologies Limited has submitted the Exchange a copy Scrutinizer's report of the Annual General Meeting held on July 30, 2026, and informed the Exchange regarding voting results. All resolutions were passed at the AGM with requisite majority.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about the publication of unaudited financial results for the quarter ended June 30, 2026, in newspapers Financial Express and Loksatta, as approved by the Board on July 29, 2026.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about the update on merger of US Subsidiary. The merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc. has been completed with the relevant local authorities/state agencies on July 30, 2026, and the merger shall become effective from August 1, 2026.
Zensar Technologies Limited
Zensar Technologies Limited held its 63rd Annual General Meeting on July 30, 2026, through video conferencing. The meeting was attended by 42 members, and the company's financial statements for the year ended March 31, 2026, were approved. The company also declared an interim dividend and re-appointed H. V. Goenka as a director.
Zensar Technologies Limited
Zensar Technologies Limited has made available the audio recording of its Q1FY27 earnings call on its website, under the Investors Corner section.
Zensar Technologies Limited
Zensar Technologies Limited has received in-principle approval for the merger of its US-based step-down subsidiaries, Bridgeview Life Sciences LLC and M3BI LLC, into its material wholly owned subsidiary, Zensar Technologies Inc., USA. The merger aims to achieve greater business synergies and operational efficiencies.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about Investor Presentation, with the company posting revenue of $159.5M, sequential quarter constant currency growth of 1.1%, and a QoQ decrease of 220bps in Profit after tax at 12.2% of revenue.
Zensar Technologies Limited
Zensar Technologies Limited has announced its consolidated financial results for Q1FY27, with revenue of $159.5M, sequential quarter constant currency growth of 1.1%, and a YoY growth of 8.9%. The company reported a Profit after tax at 12.2% of revenue, a QoQ decrease of 220bps, and net cash and cash equivalents of $317.5M at the end of Q1FY27, reflecting a YoY increase of 0.6%. The company has also announced significant wins in Q1FY27, including grants lifecycle modernization, payments and settlement operations optimization, and enterprise AI adoption acceleration.
Zensar Technologies Limited
Zensar Technologies Limited has submitted its unaudited standalone financial results for the quarter ended June 30, 2026. The company's revenue from operations was ₹7,632 million, with a total income of ₹8,366 million. The net profit after tax for the period was ₹1,835 million. The results were approved by the company's Board of Directors and reviewed by the independent auditor SR 8 C & CO LLP.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about the schedule of their Q1FY27 Results Earnings Conference Call, to be held on Thursday, July 30, 2026, at 8:30 AM IST. The call will be attended by Mr. Manish Tandon (MD and CEO), Mr. Pulkit Bhandari (CFO), and other senior management personnel. The dial-in numbers and registration link are provided for participants.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about the allotment of 21,130 fully paid equity shares of Rs. 2/- each to employees against the exercise of ESOPs, increasing the issued and subscribed share capital to Rs. 455,110,044.
Zensar Technologies Limited
Zensar Technologies Limited has informed the Exchange about the grant of 6,28,502 options to eligible employees under the 'Zensar - Employees Stock Option Scheme 2025'. The options are exercisable at Rs. 2/- per option and can be exercised within a maximum period of 5 years from the date of vesting.